PUNE, India, January 23, 2018 /PRNewswire/ --
ReportsnReports.com adds Clinical Trial Management System Market Reportis forecast to reach $1,065.6 million by 2022 from $590.0 million in 2017 at a CAGR of 12.6% during (2017-2022) driven by the increasing partnerships between biopharma companies and CROs, rising
Browse 88 Market Data Tables and 46 Figures spread through 266 Pages and in-depth TOC on "Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022" http://www.reportsnreports.com/reports/126572-clinical-trial-management-systems-ctms-market-global-trends-opportunities-challenge-and-forecasts-2011-2016-.html .
The major players operating in the clinical trial management system market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).
The APAC clinical trial management system market is expected to grow at the highest CAGR during the forecast period. Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific (APAC), and the rest of the world. The APAC market is expected to register the highest growth rate during the forecast period. Increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs are fueling the growth of the APAC CTMS market.
Inquire for DISCOUNT on "Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=126572 .
The cloud-based CTMS segment is expected to grow at the highest rate during the forecast period. On the basis of delivery mode, the global CTMS market is segmented into web-based (on-demand), licensed enterprise (on premise), and cloud-based (SaaS) segments. The cloud-based (SaaS) segment is estimated to witness the highest growth during the forecast period, primarily due to the rising adoption of cloud-based solutions in medical research studies owing to various benefits offered by them such as low cost, high security, privacy, and easy accessibility from any device.
Software segment accounted for the largess's are of the Clinical Trial Management System Market (CTMS) by component. On the basis of component, the CTMS market is segmented into software and services. The software segment is expected to have the largest share of the market. This is mainly attributed to the fierce competition in the pharmaceutical industry to introduce cost-effective novel drugs in the market, increased adoption of CTMS due to advantages provided by the same among various end users, and increasing number of clinical trials.
The pharmaceutical and biopharmaceutical companies segment is expected to hold the largest share of the clinical trial management system market in 2017. However, the major market restraints are limited awareness among researchers about the advantages of CTMS solutions and budget constraints faced by the emerging countries.
Order a copy of "Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022" research report at http://www.reportsnreports.com/purchase.aspx?name=126572 .
This report studies the CTMS market based on type, delivery mode, component, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Breakdown of supply-side primary interviews:
Another research titled eClinical Solutions Market Global Forecast to 2022 says, the global eClinical solutions market is estimated to reach $7.61 billion by 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. North America commanded the largest share of the global eClinical solutions market in 2016, followed by Europe. Companies such as Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), PAREXEL International Corporation (U.S.) have been profiled in this 163 pages research report available at http://www.reportsnreports.com/purchase.aspx?name=187723 .
Explore more reports on Healthcare Market at http://www.reportsnreports.com/market-research/healthcare/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact: Hrishikesh Patwardhan 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune - 411001. Maharashtra, India. +1-888-391-5441 email@example.com
Connect with Us: LinkedIn: http://www.linkedin.com/company/reportsnreports RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All